Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Quick Listen: Scrip's Five Must-Know Things

May 23 2022

• By Ian Haydock

Scrip Five Must Know Things — weekly audio roundup of selected global biopharma insights

Related Content

Hengrui’s PD-1 Camrelizumab Moves Step Closer To US Filing

May 16 2022

Five Late-Breaking Studies To Look Out For At ASCO

May 18 2022

Seagen CEO Search Under Way As Longtime Leader Siegall Resigns In Scandal

May 16 2022

Lilly’s Mounjaro Diabetes Approval Is First Challenge To Novo’s GLP-1 Franchise

May 13 2022

UCB Rocked By US FDA Rejection Of Blockbuster-In-Waiting Bimzelx

May 13 2022

Related Companies

UCB S.A.

Eli Lilly and Company

Novo Nordisk A/S

Seagen Inc.

Jiangsu Hengrui Pharmaceuticals

Additional Topics

Commercial Executive Changes ImmunoOncology Business Strategies Cancer Dermatology BioPharmaceutical Five Must-Know Things

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window